ENDO_2016
One Year Efficacy, Safety and Tolerability Outcomes of Endoscopic Duodenal Exclusion Using Endobarrier as an Adjunct to Glucagon-like Peptide-1 (GLP-1) Therapy in Suboptimally Controlled Type 2 Diabetes: A Randomised Controlled Trial
Presenting Author Piya Sen Gupta City Hospital
Author Russell S Drummond Glasgow Royal Infirmary
Author Barbara MC McGowan Guys and St Thomas' hospital
Author Stephanie A Amiel King's College London
Author Robert EJ Ryder City Hospital
Author Sebastian T Lugg City Hospital
Official Russell S Drummond Glasgow Royal Infirmary
File(s)
